Michelle E. Maglio
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 8
- Hematopoietic Stem Cell Transplantation 2
- Acute Myeloid Leukemia Research 1
-
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 1
- PI3K/AKT/mTOR signaling in cancer 1
- Co-authors
- Paul G. Richardson (9 shared papers)Jacob P. Laubach (6 shared papers)Cindy Varga (3 shared papers)Irene M. Ghobrial (3 shared papers)Kenneth C. Anderson (3 shared papers)Constantine S. Mitsiades (3 shared papers)Robert F. Cornell (2 shared papers)Javid J. Moslehi (2 shared papers)
- Journals
- British Journal of Haematology (3 papers)JAMA Oncology (1 paper)Expert Opinion on Drug Safety (1 paper)Current Hematologic Malignancy Reports (1 paper)Expert Review of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesFranceThailand
In The Last Decade
Michelle E. Maglio
9 papers receiving 356 citations
Peers
Comparison fields: 5 of 53
- Hematology 215
- Oncology 149
- Internal Medicine 17
- Genetics 33
- Molecular Biology 188
Countries citing papers authored by Michelle E. Maglio
This map shows the geographic impact of Michelle E. Maglio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle E. Maglio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle E. Maglio more than expected).
Fields of papers citing papers by Michelle E. Maglio
This network shows the impact of papers produced by Michelle E. Maglio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle E. Maglio. The network helps show where Michelle E. Maglio may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle E. Maglio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 73 | |
| 2 | 2016 | 69 | |
| 3 | 2015 | 60 | |
| 4 | 2012 | 59 | |
| 5 | 2018 | 33 | |
| 6 | 2016 | 26 | |
| 7 | 2018 | 21 | |
| 8 | 2017 | 17 | |
| 9 | 2014 | 1 |
About Michelle E. Maglio
Michelle E. Maglio is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Genetics, having authored 9 papers that have together received 359 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (5 papers), Hematopoietic Stem Cell Transplantation (2 papers), Histone Deacetylase Inhibitors Research (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Acute Myeloid Leukemia Research (1 paper) and Blood disorders and treatments (1 paper). The work is most often cited by research in Hematology (215 citations), Oncology (149 citations), Internal Medicine (17 citations), Genetics (33 citations) and Molecular Biology (188 citations). Michelle E. Maglio has collaborated with scholars based in United States, France and Thailand. Frequent co-authors include Paul G. Richardson, Jacob P. Laubach, Cindy Varga, Irene M. Ghobrial, Kenneth C. Anderson, Constantine S. Mitsiades, Robert F. Cornell, Javid J. Moslehi, David García and David Gailani. Their work appears in journals such as British Journal of Haematology, JAMA Oncology, Expert Opinion on Drug Safety, Current Hematologic Malignancy Reports and Expert Review of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.